Chen, Zhendong
ORCID: 0000-0002-2035-635X, Dong, Qian
ORCID: 0000-0001-7201-7643, Dokos, Charalambos
ORCID: 0000-0002-7883-2558, Boland, Jana
ORCID: 0009-0006-4660-5816, Fuhr, Uwe
ORCID: 0000-0001-7087-5871 and Taubert, Max
ORCID: 0000-0001-8925-7782
(2025).
A Joint Pharmacometric Model of Iohexol and Creatinine Administered through a Meat Meal to Assess GFR and Renal OCT2/MATE Activity.
Clinical Pharmacology & Therapeutics, 118 (2).
pp. 510-519.
Wiley.
ISSN 0009-9236
|
PDF
Clin Pharma and Therapeutics - 2025 - Chen - A Joint Pharmacometric Model of Iohexol and Creatinine Administered through a.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (335kB) |
Abstract
Accurately assessing glomerular filtration rate (GFR) from plasma creatinine concentrations is challenging in patients with unstable renal function. This study aimed to refine the understanding of creatinine kinetics for more reliable assessments of GFR and net creatinine tubular secretion (nCTS) via OCT2/MATE in humans. In a clinical study of 14 healthy volunteers, iohexol was administered intravenously as a reference GFR marker, and creatinine was introduced through a meat meal. A joint pharmacometric model was developed using dense plasma and urine sampling. Simulations were used to evaluate the effect of different creatinine volume of distribution (V d ) values on GFR estimation after acute kidney injury (AKI) and to assess the impact of limited sampling strategies on GFR and nCTS estimation. Pharmacokinetic parameters for iohexol and creatinine aligned with reported values, but a lower V d of 41% of total body weight and a nCTS fraction of 31% relative to overall creatinine clearance were observed. Commonly used equations based on single‐point creatinine measurement all overestimated GFR, with the Modification of Diet in Renal Disease (MDRD) equation performing best, followed by Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) 2009 equation. Simulations demonstrate the effect of V d estimate accuracy on detecting AKI from creatinine plasma concentrations only. Following low‐dose iohexol administration, a single plasma sample at 5 hours and a urine sample from 0 to 5 hours provided accurate estimates of both GFR and nCTS using the joint model and enabled adequate correction for incomplete urine collection. This approach shows promise for assessing renal transporter activity based on estimated nCTS.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code |
| URN: | urn:nbn:de:hbz:38-794533 |
| Identification Number: | 10.1002/cpt.3612 |
| Journal or Publication Title: | Clinical Pharmacology & Therapeutics |
| Volume: | 118 |
| Number: | 2 |
| Page Range: | pp. 510-519 |
| Number of Pages: | 10 |
| Date: | 25 August 2025 |
| Publisher: | Wiley |
| ISSN: | 0009-9236 |
| Language: | English |
| Faculty: | Faculty of Medicine |
| Divisions: | Faculty of Medicine > Pharmakologie > Instítut für Pharmakologie |
| Subjects: | Medical sciences Medicine |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/79453 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |
https://orcid.org/0000-0002-2035-635X